CLMB news

Climb Global Solutions reported record net sales and adjusted EBITDA for Q3, driven by organic growth and acquisitions. The company also expanded its European presence through a deal with NeoVAD.

Clmb Global Solutions, Inc. filed an 8-K disclosure with Exhibit 99.1. The provided content for this exhibit was empty or unextractable.

Climb Global Solutions announced the election of Peter Bell to its Board of Directors, expanding the board to five members. Bell brings significant investment and technology experience to support Climb’s global IT channel growth strategy.

Climb Bio entered into an open market sale agreement with Jefferies LLC to sell shares of common stock from time to time. This at-the-market offering provides the company with flexible capital raising capability subject to market conditions.

Climb Bio's board adopted and stockholders approved a new equity incentive plan effective July 29, 2021, authorizing 5.2 million shares for employee, director and consultant compensation. The plan includes automatic annual increases of 5% for ten years, providing a substantial equity pool for talent…

Climb Global Solutions announced it will host an Investor Day on July 7, 2026 at Nasdaq MarketSite in New York City, where CEO Dale Foster and executive leadership will present business strategy and growth opportunities. The event will be held both in-person and virtually, with a live webcast availa…

The company restated its 2021 Omnibus Incentive Plan (formerly Wayside Technology Group plan) to outline compensation framework for officers, employees, directors and consultants. The amendment clarifies equity award structures including stock options, RSUs, and cash-based awards to align employee i…